Skip to main content
. 2021 Nov;148(5):1307–1315. doi: 10.1016/j.jaci.2021.03.042

Table II.

Summary of pooled estimates for all meta-analyses undertaken, by definition of anaphylaxis used

Indicator Trigger, % of reactions treated with >1 dose of epinephrine
All
Food
Venom
Any setting (n = 36,557) Community (n = 34,121) Any setting (n = 12,615) Community (n = 10,179) Food challenge (n = 2,436) Any setting (n = 3,194)
Study-defined anaphylaxis 7.7% (6.4%-9.1%) 7.9% (6.5%-9.7%) 7.3% (5.8%-9.1%) 7.7% (6.5%-10.0%) 6.5% (4.2%-9.8%) 10.5% (6.2%-17.1%)
Cardiorespiratory anaphylaxis 9.8% (7.8%-12.2%) 9.6% (7.6%-12.1%) 9.7% (7.0%-13.4%) 9.1% (6.2%-13.1%) 10.8% (6.0%-18.8%) 11.1% (4.3%-26.0%)
Reaction treated with ≥1 dose of epinephrine 12.9% (11.2%-14.9%) 13.5% (11.5%-15.9%) 11.7% (9.9%-13.9%) 12.3% (9.9%-15.2%) 10.6% (7.9%-14.1%) 17.9% (13.2%-24.0%)
Reaction for which further epinephrine was administered by a health care professional 7.1% (5.8%-8.7%) 7.2% (5.7%-9.0%) 7.0% (5.5%-8.9%) 7.1% (5.3%-9.5%) 6.8% (4.4%-10.4%) 10.0% (5.1%-18.8%)
Epinephrine-treated reaction for which further epinephrine was administered by a health care professional 12.2% (10.4%-14.3%) 12.8% (10.6%-15.4%) 11.1% (9.4%-13.2%) 11.4% (9.1%-14.0%) 10.8% (8.0%-14.4%) 17.1% (11.3%-25.0%)

Further subgrouping of meta-analyses by reaction trigger (any trigger, food, or venom) and setting (community reactions, food challenges under medical supervision, or any setting) are listed. Data are presented as percentages (pooled estimates [95% CI]).